Tech Moves: USAFacts president stepping down; Starbucks' new COO; WSOS names leader
Steve Ballmer is hiring.
USAFacts, the data-sharing nonprofit founded by the former Microsoft CEO, is looking for a president to replace Poppy MacDonald, who is stepping down later this month. Ballmer will take the helm until a replacement is found.
The organization is seeking someone to harness the power of AI to expand access to the more than 90,000 sources of federal, state and local government data that's combed by the nonpartisan clearinghouse and presented to the public.
That person needs to be smart 'about working with engineers and envisioning where AI takes us,' Ballmer told Fast Company, which first reported MacDonald's departure. But they also need to 'have enough of that media flavor to understand how people want to consume information,' along with an 'incredible marketing gene.'
USAFacts launched in 2017 in Bellevue, Wash., and MacDonald became president a year later. The organization has attracted 640,000 newsletter subscribers, 16 million monthly visitors, and more than 65 million views of its 'Just the Facts' videos.
MacDonald was honored as one of GeekWire's 'Uncommon Thinkers' in 2023 for her leadership. At the time, Ballmer called her 'a catalyst for positive change' and said she was 'instrumental at USAFacts, fostering an environment where facts are paramount and data drives our narrative. Her approach to data in these divisive times is both refreshing and essential.'
Prior to this role, MacDonald was president of Politico USA, a news media company focused on policy and politics. She also led the National Journal and was a lead partner with the analytics and polling company Gallup. MacDonald's early roles were in communications for two U.S. lawmakers.
MacDonald told Fast Company she's taking a break before her next career move.
Other notable Pacific Northwest tech moves:
Mike Grams. (LinkedIn Photo)
— Starbucks is making changes in its C-suite:
Mike Grams is being promoted to chief operating officer after briefly serving as executive vice president, North America chief coffeehouse officer. Grams, who worked with Starbucks CEO Brian Niccol at Taco Bell, will add oversight of global coffeehouse development and global supply chain to his slate of responsibilities.
Chief Legal Officer Brad Lerman will be leaving Starbucks 'in the coming months,' Niccol announced. A replacement has not been named. Lerman came out of retirement to take the role at Starbucks. He previously worked for Medtronic, Fannie Mae and Pfizer, as well as practicing with private law firms. He was also an assistant U.S. Attorney with the Department of Justice.
Isabel Muñoz-Colón. (WSOS Photo)
— Isabel Muñoz-Colón is now executive director of the Washington State Opportunity Scholarship (WSOS).
Muñoz-Colón has centered her career on education, public service and philanthropic work. She joins WSOS from the Gates Foundation, where she was a senior program officer focused on Washington state initiatives. Previous roles include working for the City of Seattle as an education policy advisor, positions with the Quality Education Council and Office of Superintendent of Public Instruction, and chairing the Washington State Board of Education.
'WSOS is at a pivotal moment. Isabel's proven ability to build partnerships and her respected reputation in Olympia and across Washington are essential as we expand strategically and advocate for equitable workforce opportunities statewide,' said Brad Smith, WSOS board chair and Microsoft president, in a statement.
WSOS is a public-private partnership supported by state funding and private donations. The 14-year-old organization has invested in more than 22,000 students, providing them with scholarships, mentorship and career development opportunities.
Kimber Connors, WSOS's past executive director, is leading the organization's foundation.
— Costco is making multiple leadership changes, as disclosed in a new filing with the U.S. Securities and Exchange Commission:
At the end of this month, Dan Hines is retiring as Costco's senior vice president, corporate controller and principal accounting officer. Hines has served at the retail giant for 35 years and will remain an SVP until leaving the organization in January 2026.
is retiring as Costco's senior vice president, corporate controller and principal accounting officer. Hines has served at the retail giant for 35 years and will remain an SVP until leaving the organization in January 2026. Tiffany Barbre will take over Hines' roles, effective July 1. Barbre joined the company in 2005 and currently serves as vice president, assistant corporate controller.
Kevin Ruth, left, and Ola Piętka have taken roles at Govstream.ai. (LinkedIn Photos)
— Govstream.ai, a Seattle startup empowering local government agencies with technology for streamlining urban development and permitting processes, has two new hires:
Kevin Ruth was named a founding product manager for Govstream.ai. He previously held leadership roles at Seattle-area tech companies including Qualtrics; Hazel Analytics, which was acquired by Ecolab; Aduro; and Leviton.
was named a founding product manager for Govstream.ai. He previously held leadership roles at Seattle-area tech companies including Qualtrics; Hazel Analytics, which was acquired by Ecolab; Aduro; and Leviton. Ola Piętka is now founding AI engineer at the startup. Piętka, who hails from Poland, previously co-created a tool for using large language models to build interactive FAQs. She also worked for London's Curvestone and WorkflowGPT.
— Evergreen Goodwill of Northwest Washington, a nonprofit selling used goods and providing workforce training, appointed five members to its board of directors:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
a minute ago
- Fast Company
Research reveals how Delta and other airlines use AI to set ticket prices
Booking your last minute summer getaway? Delta recently revealed to what extent it's using artificial intelligence to set ticket prices. And while this is just the beginning of the AI revolution in pricing, here's some insight into how it's working so far, and may expand to other industries in the future. What happened? Delta recently made headlines, sparking backlash from consumer groups and concern from Congress, when president Glen Hauenstein revealed in the airline's latest earnings call it's currently using AI for 3% of domestic pricing, with the goal of about 20% by the end of the year. 'So, we're in heavy testing phase. We like what we see. We like it a lot and we're continuing to roll it out,' Hauenstein said. 'But we're going to take our time and make sure that the rollout is successful… the more data it has and the more cases we give it, the more it learns. And we're really excited about partnering with Fetcherr.' When Fast Company reached out to Delta about how this might affect consumers, the airline referred to its letter to Senators Ruben Gallego, Richard Blumenthal and Mark Warner which stated it is not 'using, and [does not] intend to use, AI for 'individualized' pricing or 'surveillance' pricing, leveraging consumer-specific personal data, such as sensitive personal circumstances or prior purchasing activity to set individualized prices… There is no fare product Delta has ever used, is testing or plans to use that targets customers with individualized prices based on personal data.' What AI will likely end up doing, according to ThePointsGuy's Clint Henderson, is create ' dynamic pricing model on steroids ' pinpointing flight prices with greater accuracy and a whole lot faster. What variables go into AI airline flight pricing? Delta has partnered with Israel-based software startup Fetcherr, which utilizes its Large Market Model (LLM) to decode intricate market behavior and forecast financial trends, and coupled it with historical and current data. Fetcherr's approach encompasses a comprehensive range of factors that influence market dynamics, and its recent white paper lists a few of those variables that go into airline flight pricing, namely, 'seat availability, current news, weather conditions, significant events, flight schedules, and even fluctuating oil prices, among others.' The question on most passengers' minds is whether working with companies like Fetcherr will lead airlines to use personalized pricing. Like Delta, Fetcherr told Fast Company its technology has been developed to streamline processes already in place at companies and 'does not allow for individualized or personalized pricing.' 'Our Generative AI system does not and will not use, collect or receive any Personally Identifiable Information (PII) [and] remains steadfast in our commitment to transparency and to our compliance with applicable regulations,' a spokesperson for Fetcherr said in a statement. Delta isn't the only airline using AI In its white paper, Fetcherr said it has also partnered with: Virgin Atlantic, UK; Viva Aerobus, Mexico, West Jet, Canada; and Royal Air Maroc—with the primary focus on optimizing key aspects such as pricing and inventory management. What's next for Fetcherr AI after airline pricing? Looking ahead, Fetcherr said it plans to expand into other industries like hospitality, insurance, commerce, and capital markets; with their models expanding beyond pricing and inventory decisions, to more complex challenges like making supply chain decisions and engaging in B2B strategic decision making.
Fox News
2 minutes ago
- Fox News
SC gubernatorial candidate Nancy Mace: We have a huge opportunity to address our challenges
Rep. Nancy Mace, R-S.C., opens up about her bid for South Carolina governor on 'The Story.'
CNN
2 minutes ago
- CNN
Analysis: Trump's cynical bait-and-switch on IVF
To hear President Donald Trump tell it, he wields an almost magical ability to lower Americans' health care costs. Yet that doesn't seem to extend to one area where he made explicit 2024 campaign promises: in vitro fertilization. Just this weekend, Trump claimed he had lowered prescription drug costs as much as 1,500%. 'I don't mean 50%,' Trump clarified. 'I mean 14, 1,500%.' This is obviously false and innumerate. You can't cut something more than 100%. It would mean drug companies were not only giving their drugs away for free, but actually paying people exorbitant sums to take them. But the self-proclaimed 'father of IVF' appears to be an absentee dad. His past vows to make the expensive and arduous IVF process 'free,' or at least require insurers to cover it, would fall under that seemingly magical umbrella as well, of course. But contrasting with his repeated pressure on drugmakers to lower costs — regardless of whether it's in his power to do so — Trump and his administration haven't done much of anything to make his IVF promises a reality. And it sounds like they've given up trying, to the extent they meant to pursue this policy in the first place. Indeed, this looked a whole lot like a cynical pander during the 2024 campaign. And the administration's actions since then only seem to confirm it. The Washington Post reported this weekend that the Trump administration has no actual plan to get insurers to cover IVF, more than six months into the new administration. The only concrete action Trump has taken on this front was back in February, when Trump instructed his domestic policy council to submit 'recommendations' on 'aggressively reducing out-of-pocket and health plan costs for IVF treatment.' He gave it 90 days. Those recommendations were due in mid-May. But there is still no word on what, if any, recommendations were produced, and the administration last week reportedly declined to comment on the situation. Fast forward to today, and the White House is apparently waving the white flag on Trump's biggest IVF promise. White House officials reportedly blamed inaction on the fact that Trump can't legally do this on his own and would need Congress to pass a law. But that's not exactly the kind of impediment that Trump usually respects. His first six-plus months back in the presidency are rife with attempts to take bold and legally dubious executive actions that challenge the courts to stop him and companies to defy him. That's even applied to health care specifically. Just last week, Trump sent letters to 17 major pharmaceutical company CEOs giving them 60 days to comply with an executive order that sought to lower prescription drug prices — even as experts say he has no such authority. Trump has also sought to squeeze drugmakers in other ways, including threatening tariffs on pharmaceutical imports. But the White House hasn't engaged in those hardball tactics to make insurers cover IVF. Administration officials aren't putting any public pressure on Congress to pass the law it says it needs, either, and they don't even seem to want to talk about the situation. And if that's the new reality, it was entirely predictable — and predicted. It was almost exactly a year ago when Trump debuted this promise. 'The government is going to pay for [IVF], or we're going to get — we'll mandate your insurance company to pay for it, which is going to be great. We're going to do that,' Trump said in August 2024. 'We want to produce babies in this country, right?' That's not a 'we'll try to make this happen' promise. That's a 'we're going to make this happen' promise. By October, Trump had declared himself the 'father of IVF' (something his campaign later labeled a joke). And Vice President JD Vance at his 2024 debate declared that making IVF more 'accessible' was core to the GOP's health agenda. Even at the time, though, many dismissed the promises as hot air. Trump and his campaign were dealing with political fallout from strict red-state abortion bans, some of which had imperiled IVF access and coverage. Rhetorically bear-hugging IVF, a practice that's widely popular with voters, made sense. But free IVF or ubiquitous insurance coverage never seemed an especially serious idea. Not only are IVF costs very expensive, stretching into tens of thousands of dollars per treatment, but many anti-abortion conservatives are starkly opposed to it. The process involves producing embryos that are never used and are often destroyed, creating a moral quandary for anti-abortion blocs that believe life begins at conception. The idea that a Republican administration would spearhead making that cheaper — or even making the government pay for the creation of later-discarded embryos — was always far-fetched. Because of all of this, many Republican lawmakers strongly rejected Trump's proposal when he debuted it. Some even acknowledged that it appeared to be a rather transparent bit of pandering that was not to be taken seriously. 'People get emotional about an issue, so they decide to completely pander and go way over a position they never really supported because they're afraid people accuse them,' Conservative Sen. Rand Paul of Kentucky said at the time. It appears that's precisely what happened here. That's bad news for anybody who might have been counting on this proposal. These issues, after all, deal with one of the most heart-wrenching circumstances that many families will ever confront: problems conceiving children. The cost is prohibitive for many people. An October Ipsos poll also showed many Americans supported the idea. They said by a 55-26% margin that Congress should pass a law requiring insurers to cover IVF. The Washington Post back in February profiled a young woman who had heard Trump deliver the promise and reluctantly voted for him. When the White House in February announced its limited IVF recommendations, saying it was delivering on Trump's promises, she called it 'bullsh*t.' It's getting more and more difficult to quibble with that summary.
